Clinical Trial Update: A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses [Phase 2, Phase 3]

View source ↗

Summary

A pilot Phase 2/3 trial comparing immunogenicity of Fendrix versus double-dose Engerix B in HIV-infected non-responders to standard Hepatitis B vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• Fendrix

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: HIV, Communicable Diseases | Phase 2, Phase 3 | Status: COMPLETED